Blog
RSS FeedPosted by Michael Wonder on 29 Jan 2020
Documents disclosed to the EMA as part of an MA application process are not presumed to be confidential
28 January 2020 - On 22 January 2020 the CJEU handed down two decisions in which it decided that the ...
Posted by Michael Wonder on 22 Jan 2020
Court of Justice upholds EMA’s approach to transparency
22 January 2020 - EMA welcomes today’s two appellate judgments by the Court of Justice that confirmed, in clear and ...
Posted by Michael Wonder on 20 Jan 2020
Talkin’ about a resolution: issues in the push for greater transparency of medicine prices
20 January 2020 - At the 2019 World Health Assembly, a significant new resolution was agreed by most countries to start ...
Posted by Michael Wonder on 10 Jan 2020
Defending transparency at European drug regulator
8 January 2020 - Forthcoming judgment must uphold public access to clinical data ...
Posted by Michael Wonder on 18 Dec 2019
Price disclosure 2020 April cycle outcomes summary
18 December 2019 - The summary of price disclosure price reductions for the 2020 April Cycle has now been published. ...
Posted by Michael Wonder on 05 Dec 2019
Hospital groups sue to block price transparency rule
4 December 2019 - Health care providers say disclosure requirement pushed by Trump violates First Amendment. ...
Posted by Michael Wonder on 27 Nov 2019
How to navigate specialist fees in the private health system
26 November 2019 - Have you ever taken up private health insurance, only to end up hundreds or thousands of ...
Posted by Michael Wonder on 21 Nov 2019
Transparency is a first step in bringing down drug costs for American seniors, families
21 November 2019 - Wherever I go — be it to school events, county fairs, town halls, or even the ...
Posted by Michael Wonder on 18 Nov 2019
To lower costs, Trump to force hospitals to reveal price of care
15 November 2019 - The Trump administration on Friday announced it would begin forcing hospitals to publicly disclose the discounted ...
Posted by Michael Wonder on 18 Nov 2019
Improving transparency in decision models: current issues and potential solutions
23 October 2019 - Decision-analytic models have become an essential tool used to inform health technology assessments. ...
Posted by Michael Wonder on 18 Nov 2019
NICE, in confidence: an assessment of redaction to obscure confidential information in single technology appraisals by the National Institute for Health and Care Excellence
17 November 2019 - Health technology assessment aims to provide a transparent framework within which normative judgements can be applied for ...
Posted by Michael Wonder on 12 Oct 2019
Canada's decision to make public more clinical trial data puts pressure on FDA
11 October 2019 - Last March, Canada's department of health changed the way it handles the huge amount of data ...
Posted by Michael Wonder on 01 Oct 2019
Why transparency in drug pricing is more complicated than it seems
1 October 2019 - Transparency has become a prominent topic in debates about health care, particularly when it comes to ...
Posted by Michael Wonder on 30 Sep 2019
1 October 2019 price disclosure confirmed prices
30 September 2019 - Confirmed 1 October 2019 prices resulting from the 2019 October Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 09 Sep 2019
Achieving appropriate model transparency: challenges and potential solutions for making value‑based decisions in the United States
5 September 2019 - Transparency in decision modeling remains a topic of rigorous debate among healthcare stakeholders, given tensions between the ...